Patents by Inventor Grant Weaver
Grant Weaver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210220756Abstract: A scum removal system for use with a wastewater treatment clarification tank containing wastewater is provided and includes a debris intake conduit, a debris discharge conduit, and a pump article. The pump article is configured to be in flow communication with the debris intake conduit and the debris discharge conduit, wherein the pump article and debris intake conduit are configured to generate a suction within the debris intake conduit and wherein the debris intake conduit is configured to be located proximate the wastewater.Type: ApplicationFiled: April 5, 2021Publication date: July 22, 2021Inventor: Grant Weaver
-
Patent number: 11000585Abstract: The majority of the mortality observed in young pigs occurs between three and five weeks post-weaning for S. suis infections and between four and six weeks post-weaning for H. parasuis and Actinobacillus suis infections. Clinical disease control associated with S. suis, A. suis and H. parasuis has been attempted using antibiotic treatment, by controlled exposure with live organisms, and by vaccination, using either inactivated commercial or autogenous bacterins administered parenterally. A similar lack of protection in very young pigs is observed with various viruses including swine influenza virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus and rotavirus. Disclosed herein is an immunogenic composition comprising inactivated antigens and a mucosal adjuvant.Type: GrantFiled: March 14, 2019Date of Patent: May 11, 2021Assignee: Phibro Animal Health CorporationInventors: Grant Weaver, Jeffrey Alan Kula, Boh Chang Lin, Karen Brown, Wesley W. Johnson, Michael Dennis Murphy
-
Patent number: 10967299Abstract: A scum removal system for use with a wastewater treatment clarification tank containing wastewater is provided and includes a debris intake conduit, a debris discharge conduit, and a pump article. The pump article is configured to be in flow communication with the debris intake conduit and the debris discharge conduit, wherein the pump article and debris intake conduit are configured to generate a suction within the debris intake conduit and wherein the debris intake conduit is configured to be located proximate the wastewater. Additionally, the debris intake conduit is sloped downwardly at a debris intake conduit angle ?, and the second discharge conduit is sloped downwardly at a debris discharge conduit angle ?.Type: GrantFiled: April 11, 2018Date of Patent: April 6, 2021Inventor: Grant Weaver
-
Patent number: 10918711Abstract: The majority of the mortality observed in young pigs occurs between three and five weeks post-weaning for S. suis infections and between four and six weeks post-weaning for H. parasuis and Actinobacillus suis infections. Clinical disease control associated with S. suis, A. suis and H. parasuis has been attempted using antibiotic treatment, by controlled exposure with live organisms, and by vaccination, using either inactivated commercial or autogenous bacterins administered parenterally. A similar lack of protection in very young pigs is observed with various viruses including swine influenza virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus and rotavirus. Disclosed herein is an immunogenic composition comprising inactivated antigens and a mucosal adjuvant.Type: GrantFiled: April 17, 2019Date of Patent: February 16, 2021Assignee: Phibro Animal Health CorporationInventors: Grant Weaver, Jeffrey Alan Kula, Boh Chang Lin, Karen Brown, Wesley W. Johnson, Michael Dennis Murphy
-
Publication number: 20190247490Abstract: The majority of the mortality observed in young pigs occurs between three and five weeks post-weaning for S. suis infections and between four and six weeks post-weaning for H. parasuis and Actinobacillus suis infections. Clinical disease control associated with S. suis, A. suis and H. parasuis has been attempted using antibiotic treatment, by controlled exposure with live organisms, and by vaccination, using either inactivated commercial or autogenous bacterins administered parenterally. A similar lack of protection in very young pigs is observed with various viruses including swine influenza virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus and rotavirus. Disclosed herein is an immunogenic composition comprising inactivated antigens and a mucosal adjuvant.Type: ApplicationFiled: April 17, 2019Publication date: August 15, 2019Applicant: Phibro Animal Health CorporationInventors: Grant Weaver, Jeffrey Alan Kula, Boh Chang Lin, Karen Brown, Wesley W. Johnson, Michael Dennis Murphy
-
Publication number: 20190231864Abstract: The majority of the mortality observed in young pigs occurs between three and five weeks post-weaning for S. suis infections and between four and six weeks post-weaning for H. parasuis and Actinobacillus suis infections. Clinical disease control associated with S. suis, A. suis and H. parasuis has been attempted using antibiotic treatment, by controlled exposure with live organisms, and by vaccination, using either inactivated commercial or autogenous bacterins administered parenterally. A similar lack of protection in very young pigs is observed with various viruses including swine influenza virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus and rotavirus. Disclosed herein is an immunogenic composition comprising inactivated antigens and a mucosal adjuvant.Type: ApplicationFiled: March 14, 2019Publication date: August 1, 2019Applicant: Phibro Animal Health CorporationInventors: Grant Weaver, Jeffrey Alan Kula, Boh Chang Lin, Karen Brown, Wesley W. Johnson, Michael Dennis Murphy
-
Patent number: 10279031Abstract: The majority of the mortality observed in young pigs occurs between three and five weeks post-weaning for S. suis infections and between four and six weeks post-weaning for H. parasuis and Actinobacillus suis infections. Clinical disease control associated with S. suis, A. suis and H. parasuis has been attempted using antibiotic treatment, by controlled exposure with live organisms, and by vaccination, using either inactivated commercial or autogenous bacterins administered parenterally. A similar lack of protection in very young pigs is observed with various viruses including swine influenza virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus and rotavirus. Disclosed herein is an immunogenic composition comprising inactivated antigens and a mucosal adjuvant.Type: GrantFiled: May 11, 2017Date of Patent: May 7, 2019Assignee: Phibro Animal Health CorporationInventors: Grant Weaver, Jeffrey Alan Kula, Boh Chang Lin, Karen Brown, Wesley W. Johnson, Michael Dennis Murphy
-
Publication number: 20180290075Abstract: A scum removal system for use with a wastewater treatment clarification tank containing wastewater is provided and includes a debris intake conduit, a debris discharge conduit, and a pump article. The pump article is configured to be in flow communication with the debris intake conduit and the debris discharge conduit, wherein the pump article and debris intake conduit are configured to generate a suction within the debris intake conduit and wherein the debris intake conduit is configured to be located proximate the wastewater. Additionally, the debris intake conduit is sloped downwardly at a debris intake conduit angle ?, and the second discharge conduit is sloped downwardly at a debris discharge conduit angle ?.Type: ApplicationFiled: April 11, 2018Publication date: October 11, 2018Inventor: Grant Weaver
-
Publication number: 20170326226Abstract: The majority of the mortality observed in young pigs occurs between three and five weeks post-weaning for S. suis infections and between four and six weeks post-weaning for H. parasuis and Actinobacillus suis infections. Clinical disease control associated with S. suis, A. suis and H. parasuis has been attempted using antibiotic treatment, by controlled exposure with live organisms, and by vaccination, using either inactivated commercial or autogenous bacterins administered parenterally. A similar lack of protection in very young pigs is observed with various viruses including swine influenza virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus and rotavirus. Disclosed herein is an immunogenic composition comprising inactivated antigens and a mucosal adjuvant.Type: ApplicationFiled: May 11, 2017Publication date: November 16, 2017Applicant: Phibro Animal Health CorporationInventors: Grant Weaver, Jeffrey Alan Kula, Boh Chang Lin, Karen Brown, Wesley W. Johnson, Michael Dennis Murphy